VRI multiplex  test

VRI multiplex test

Rapid test for COVID-19 (SARS-CoV-2)

Results in less than 2,5 hours

The Vivalytic VRI test (Viral Respiratory Tract Infections) checks the patient’s sample for the SARS CoV-2 virus, which can lead to COVID-19, as well as other possible viral respiratory diseases. To prevent the continued rapid spread of COVID-19, it is necessary to identify infectious patients with and without symptoms. With the Vivalytic VRI test, physicians can quickly and efficiently distinguish between different infections with very similar symptoms, like influenza, and immediately begin the appropriate treatment. The test delivers a reliable result based on WHO guidelines in less than 2.5 hours at the point of care, i.e. in close proximity to where the patient’s sample was collected. This means a time-consuming logistics chain, in which the samples have to be transported, is no longer necessary.

VRI multiplex test

Sample material:
Nasopharyngeal / Oropharyngeal swab samples

Integration of sample preparation (including process controls), DNA amplification, detection (μArray) and analysis on a single cartridge

Nucleic acid based testing for direct identification of viral pathogens

VRI Multiplex Test in practice

The Vivalytic Workflow

VRI cartridge

The Vivalytic platform is so easy to use that it can be handled in any clinic or medical practice without the need for laboratory personnel.

hand holds VRI cartridge

The sample is taken from the patient's nose or throat using a swab and placed in the cartridge without any complex preparation.

VRI cartridge in Vivalytic analyser

The Vivalytic analyser then fully automatically processes the cartridge, which already contains all the reagents required for the test.

Since the system in each cartridge is isolated, the risk of infection during handling is minimized.

The analyser for your institution 

The Vivalytic analysers required for the COVID 19 rapid test can be purchased by medical institutions such as doctors’ surgeries, laboratories, hospitals and health centres. The test can be performed directly at the point of care.

Are you interested in a Vivalytic Analyser for your institution?
Then please contact one of our distribution partners.

Vivalytic VRI Test in the press-media

Analyser and 4 cartridge

The COVID-19-(SARS-CoV-2-) rapid testing kit for the Vivalytic platform developed by Bosch delivers reliable results at the point of care in less than 2.5 hours.